FDA formally classifies preeclampsia prognostic blood tests
A June 26, 2026 Federal Register notice placed these pregnancy blood tests in Class II with special controls, clearing a defined path for more of them.
Health News
Reporting on guideline revisions, drug approvals, safety warnings and newly published studies affecting women's care, each traced to the source document.
ACOG issues its own 2026 immunization schedule for pregnancy
The college's June 18, 2026 schedule, endorsed by more than a dozen medical societies, names four routine vaccines in pregnancy.
Women's health venture funding fell to $1.58 billion in 2025
SVB's 2026 investment report shows a steep slide from the 2024 record — and a striking valuation premium for AI-focused startups.
Appeals court would bar mailing mifepristone; access unchanged for now
On May 1, 2026, the Fifth Circuit reinstated in-person dispensing for mifepristone; the order had not taken effect as of mid-May.
Title X clinics raced to reapply for funding before the April 1 deadline
New federal guidance issued in March 2026 forced safety-net contraceptive providers through a compressed reapplication cycle.
Nexplanon now requires REMS certification for every inserter
A February 2026 FDA label update and new REMS program changed who can insert and remove the contraceptive implant.